etoposide has been researched along with Rhabdoid Tumor in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (55.00) | 29.6817 |
| 2010's | 7 (35.00) | 24.3611 |
| 2020's | 2 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aye, J; Beierle, EA; Clay, MR; Coleman, A; Hoppmann, A; Mroczek-Musulman, E; Ranganathan, S; Tynes, C; Whelan, KF; Williams, AP; Williams, GR | 1 |
| Almutereen, M; Elborai, Y; Hafez, H; Lee, MA; Lehmann, L; Maher, OM | 1 |
| Chi, J; Lei, L; Li, T; Li, Z; Liu, P; Wang, J; Wang, X; Yan, H; Yang, B | 1 |
| Cormenzana, M; García-Esparza, E; Hernández-Marqués, C; Lassaletta, A; Madero-López, L | 1 |
| Borchardt, C; Clemens, D; Dirksen, U; Frühwald, MC; Kool, M; Unland, R | 1 |
| Iwafuchi, H; Iwama, J; Kiyotani, C; Matsuoka, K; Morota, N; Ogiwara, H; Terashima, K | 1 |
| Kawamoto, H; Kobayashi, E; Nakatani, F; Yasui, N; Yoshida, A | 1 |
| Biegel, JA; Cho, YJ; Evans, JA; Greulich, H; McKenna, ES; Moreau, LA; Pomeroy, SL; Roberts, CW; Sansam, CG; Thom, CS | 1 |
| Boldrini, R; Cozza, R; De Ioris, MA; De Sio, L; Donfrancesco, A; Fidani, P; Garrè, ML; Ilari, I; Milano, GM; Serra, A | 1 |
| Hara, T; Hatano, M; Kinoshita, Y; Koga, Y; Kohashi, K; Matsuzaki, A; Oda, Y; Saito, Y; Suminoe, A; Taguchi, T; Tajiri, T; Tsuneyoshi, M | 1 |
| Athale, UH; Barr, R; Duckworth, J; Odame, I | 1 |
| Bartels, U; Bouffet, E; Finkelstein-Shechter, T; Gassas, A; Hawkins, C; Huang, A; Janzen, L; Laura, J; Mabbott, D; Tabori, U; Taylor, M | 1 |
| Baek, HJ; Kim, HS; Lim, DH; Park, ES; Park, HJ; Park, KD; Sung, KW; Won, SC | 1 |
| Kawaguchi, T; Kumabe, T; Tominaga, T; Watanabe, M | 1 |
| Beckwith, JB; Breslow, NE; Coccia, P; Coppes, MJ; Cotton, CA; Dome, JS; Donaldson, M; Green, DM; Grundy, PE; Haase, GM; Kalapurakal, JA; Kletzel, M; Macklis, RM; Malogolowkin, M; Perlman, EJ; Ritchey, ML; Shamberger, RC; Weetman, RM | 1 |
| Dome, JS; Hareyama, M; Hatakeyama, N; Hirama, T; Hori, T; Kudoh, T; Kuroiwa, Y; Matsuno, T; Mizue, N; Nui, A; Oda, T; Suzuki, N; Tsutsumi, H; Yamamoto, M; Yokoyama, S | 1 |
| Ang, LC; Dennis, KE; Fisher, BJ | 1 |
| Hosoi, H; Iehara, T; Iwai, N; Koizumi, M; Misawa, A; Miyaji, M; Nishimura, T; Sugimoto, T; Tokiwa, K; Tsuchiya, K; Yagyu, S; Yanagisawa, A | 1 |
| Hashiguchi, Y; Inoue, T; Kobayashi, Y; Maed, K; Tsuda, H; Umesaki, N; Yamamoto, K | 1 |
| Castellino, SM; DeVoe, M; Kalwinsky, D; Powers, R | 1 |
1 review(s) available for etoposide and Rhabdoid Tumor
| Article | Year |
|---|---|
Childhood atypical teratoid rhabdoid tumor of the central nervous system: a meta-analysis of observational studies.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Craniotomy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Infant; Infant, Newborn; Injections, Spinal; Kaplan-Meier Estimate; Male; Prognosis; Prospective Studies; Rhabdoid Tumor; Spinal Neoplasms; Teratoma; Treatment Outcome; Vincristine | 2009 |
2 trial(s) available for etoposide and Rhabdoid Tumor
| Article | Year |
|---|---|
A multimodal strategy based on surgery, radiotherapy, ICE regimen and high dose chemotherapy in atypical teratoid/rhabdoid tumours: a single institution experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Humans; Ifosfamide; Infant; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Neurosurgical Procedures; Radiotherapy; Rhabdoid Tumor; Teratoma; Thiotepa; Tomography, X-Ray Computed | 2009 |
Tandem high-dose chemotherapy and autologous stem cell transplantation in young children with atypical teratoid/rhabdoid tumor of the central nervous system.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Humans; Induction Chemotherapy; Infant; Male; Prospective Studies; Recurrence; Rhabdoid Tumor; Salvage Therapy; Stem Cell Transplantation; Survival Rate; Thiotepa; Transplantation, Autologous | 2012 |
17 other study(ies) available for etoposide and Rhabdoid Tumor
| Article | Year |
|---|---|
Partial response to carboplatin, etoposide phosphate, and atezolizumab in a pediatric patient with high-grade metastatic tumor with rhabdoid and focal neuroendocrine features.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Etoposide; Humans; Liver Neoplasms; Male; Neoplasm Grading; Neuroendocrine Tumors; Organophosphorus Compounds; Rhabdoid Tumor; Treatment Outcome | 2020 |
Changes in glomerular filtration rate and clinical course after sequential doses of carboplatin in children with embryonal brain tumors undergoing autologous stem cell transplantation.
Topics: Acute Kidney Injury; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Cisplatin; Creatinine; Dose-Response Relationship, Drug; Etoposide; Female; Glomerular Filtration Rate; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Medulloblastoma; Retrospective Studies; Rhabdoid Tumor; Teratoma; Thiotepa; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome | 2020 |
Insulin-like growth factor 2 axis supports the serum-independent growth of malignant rhabdoid tumor and is activated by microenvironment stress.
Topics: Autocrine Communication; Cell Line, Tumor; Cell Proliferation; Cell Survival; Epirubicin; Etoposide; Gene Expression Regulation, Neoplastic; Gene Knockout Techniques; Humans; Insulin-Like Growth Factor II; Models, Biological; Proto-Oncogene Proteins c-akt; Receptor, IGF Type 1; Receptor, IGF Type 2; Rhabdoid Tumor; Signal Transduction; SMARCB1 Protein; Stress, Physiological; Tumor Microenvironment | 2017 |
All children with malignant rhabdoid tumors should be treated initially with intensive chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Humans; Ifosfamide; Infant; Male; Mediastinal Neoplasms; Rhabdoid Tumor; Tomography, X-Ray Computed; Vincristine | 2015 |
Analysis of the antiproliferative effects of 3-deazaneoplanocin A in combination with standard anticancer agents in rhabdoid tumor cell lines.
Topics: Adenosine; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Azacitidine; Cell Line, Tumor; Cell Proliferation; Decitabine; Doxorubicin; Enhancer of Zeste Homolog 2 Protein; Epigenesis, Genetic; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Hydroxamic Acids; Molecular Targeted Therapy; Polycomb Repressive Complex 2; Rhabdoid Tumor; Vorinostat | 2015 |
Neoadjuvant chemotherapy for brain tumors in infants and young children.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma; Carcinoma, Embryonal; Child; Child, Preschool; Choroid Plexus Neoplasms; Cisplatin; Cyclophosphamide; Drug Administration Schedule; Ependymoma; Etoposide; Female; Glioblastoma; Humans; Infant; Magnetic Resonance Imaging; Male; Neoadjuvant Therapy; Neuroectodermal Tumors, Primitive; Retrospective Studies; Rhabdoid Tumor; Second-Look Surgery; Treatment Outcome; Vincristine | 2015 |
Successful Treatment of Extra-Renal Noncerebral Rhabdoid Tumors with VIDE.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Rhabdoid Tumor; Vincristine | 2016 |
Loss of the epigenetic tumor suppressor SNF5 leads to cancer without genomic instability.
Topics: Animals; Cell Line, Tumor; Chromosomal Proteins, Non-Histone; Cisplatin; Cyclin D1; Diploidy; DNA Damage; DNA Repair; DNA-Binding Proteins; Epigenesis, Genetic; Etoposide; G2 Phase; Genomic Instability; Histones; Humans; Mice; Neoplasms; Phenotype; Polymorphism, Single Nucleotide; Protein Transport; Rhabdoid Tumor; SMARCB1 Protein; Transcription Factors | 2008 |
Long-term survival after autologous peripheral blood stem cell transplantation in two patients with malignant rhabdoid tumor of the kidney.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Infant; Kidney Neoplasms; Male; Melphalan; Prognosis; Rhabdoid Tumor; Survival Rate; Tomography, X-Ray Computed; Transplantation, Autologous; Treatment Outcome; Vincristine | 2009 |
Atypical teratoid or rhabdoid tumors: improved outcome with high-dose chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Etoposide; Female; Humans; Infant; Male; Neoplasm Metastasis; Radiotherapy Dosage; Retrospective Studies; Rhabdoid Tumor; Survival Rate; Teratoma; Treatment Outcome; Vincristine | 2010 |
Atypical teratoid/rhabdoid tumour with leptomeningeal dissemination in an adult.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Cisplatin; Combined Modality Therapy; Disease Progression; Etoposide; Humans; Ifosfamide; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Methotrexate; Neoplasm Invasiveness; Rhabdoid Tumor; Teratoma | 2004 |
Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study.
Topics: Adolescent; Anaplasia; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Infant; Infant, Newborn; Kidney; Kidney Neoplasms; Male; Neoplasm Staging; Nephrectomy; Prognosis; Prospective Studies; Radiotherapy; Rhabdoid Tumor; Sarcoma, Clear Cell; Survival Analysis; Vincristine; Wilms Tumor | 2006 |
Treatment of stage IV malignant rhabdoid tumor of the kidney (MRTK) with ICE and VDCy: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Kidney Neoplasms; Remission Induction; Rhabdoid Tumor; Vincristine | 2006 |
Malignant teratoid/rhabdoid tumour: long-term survival.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child, Preschool; Combined Modality Therapy; Etoposide; Female; Humans; Infant; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Rhabdoid Tumor; Survivors; Teratoma; Treatment Outcome; Vincristine | 2007 |
Continuous remission in an infant with chest wall malignant rhabdoid tumor after relapse.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Infant; Male; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Remission Induction; Rhabdoid Tumor; Salvage Therapy; Survivors; Thoracic Neoplasms; Vincristine | 2007 |
Malignant rhabdoid tumour of the uterine cervix.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Female; Humans; Hysterectomy; Ifosfamide; Rhabdoid Tumor; Uterine Neoplasms | 2001 |
Abdominal rhabdoid tumor presenting as fetal hydrops: a case report.
Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cesarean Section; Etoposide; Fatal Outcome; Fetal Diseases; Humans; Hydrops Fetalis; Infant, Newborn; Multiple Organ Failure; Rhabdoid Tumor; Ultrasonography, Prenatal | 2001 |